Embolization of Pseudoaneurysms is Associated With Improved Outcomes in Blunt Splenic Trauma.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
01 2024
Historique:
received: 28 02 2023
revised: 27 07 2023
accepted: 27 08 2023
medline: 24 11 2023
pubmed: 15 10 2023
entrez: 15 10 2023
Statut: ppublish

Résumé

The necessity of angioembolization for all splenic pseudoaneurysms (PSAs) is unknown after blunt trauma. We compared the outcomes of patients with PSAs managed with splenic artery embolization (EMBO) versus no embolization (NO-EMBO). We retrospectively reviewed all patients with blunt splenic trauma and PSA on initial computed tomography scan admitted to an academic, urban, Level I trauma center from 2016 to 2021. Patients who had emergent splenectomy or died before discharge were excluded. Demographics, injury and computed tomography characteristics, and details regarding angiography, if pursued, were collected. The primary outcome was failure of nonoperative management (FNOM), as defined by need for delayed splenectomy for the EMBO group versus delayed splenectomy or embolization for the NO-EMBO group. One hundred and fifty-six patients were in the final study population, of which 96 (61.5%) were in the EMBO group and 60 (38.5%) were in the NO-EMBO group. Patient demographics and mechanism of injury were similar between the two cohorts. The two cohorts had similar imaging findings, however, EMBO patients had more compartments with hemoperitoneum (2 versus 1, P < 0.01). Patients who underwent embolization had a lower FNOM rate (3.1% versus 13.3%, P = 0.02). Splenic artery embolization in the setting of PSA is associated with lower rates of FNOM versus nonembolization. It is unclear if addressing the PSA itself with embolization drives the decreased FNOM rate.

Identifiants

pubmed: 37839096
pii: S0022-4804(23)00483-3
doi: 10.1016/j.jss.2023.08.054
pii:
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

656-662

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Navpreet K Dhillon (NK)

Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, Maryland.

Melike N Harfouche (MN)

Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, Maryland.

Kristy L Hawley (KL)

Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, Maryland.

Joseph J DuBose (JJ)

Department of Surgery and Perioperative Care, Dell Medical School at the University of Texas, Austin, Texas.

Rosemary A Kozar (RA)

Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, Maryland.

Thomas M Scalea (TM)

Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, Maryland. Electronic address: tscalea@som.umaryland.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH